NCT06307093 2024-03-12
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
R-Pharm
Phase 1 Unknown
Clinical Trials
9 trialsNCT04149691 2024-02-07
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
Phase 1 Unknown
NCT05498597 2023-10-19
AMT-151 in Patients With Selected Advanced Solid Tumours
Multitude Therapeutics Inc.
Phase 1 Unknown
NCT04363242 2023-04-12
A Study to Find the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN004 in People in Patients With Epithelial Cancers With EGFR Expressions
Synermore Biologics Co., Ltd.
Phase 1 Unknown
NCT05235607 2022-02-11
Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors
Sichuan University
Phase 1 Unknown
NCT04973098 2021-11-04
Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma
Peking University
Phase 1 Unknown
NCT03908840 2019-04-09
Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma
Evolve Biologics
Phase 1 Unknown
NCT02977364 2016-11-30
A Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid Tumours
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT00396617 2012-07-02
Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy
University Hospital, Strasbourg, France
Phase 1 Unknown